Acromegaly due to ectopic secretion of GHRH by bronchial carcinoid in a patient with empty sella

[1]  F. Santeusanio GH and primary empty sella , 2002, Journal of endocrinological investigation.

[2]  M. Papotti,et al.  Expression of somatostatin receptor types 2, 3 and 5 in biopsies and surgical specimens of human lung tumours , 2001, Virchows Archiv.

[3]  S. Asa,et al.  Growth hormone‐releasing hormone (GHRH) and GHRH receptor (GHRH‐R) isoform expression in ectopic acromegaly , 2001, Clinical endocrinology.

[4]  T. Pfammatter,et al.  Carcinoid syndrome, acromegaly, and hypoglycemia due to an insulin-secreting neuroendocrine tumor of the liver. , 2001, The Journal of clinical endocrinology and metabolism.

[5]  G. Bussolati,et al.  Post-incubation Heating Significantly Improves Tyramide Signal Amplification , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[6]  P. Lichter,et al.  Acromegaly caused by secretion of growth hormone by a non-Hodgkin's lymphoma. , 2000, The New England journal of medicine.

[7]  F. Casanueva,et al.  Criteria for cure of acromegaly: a consensus statement. , 2000, The Journal of clinical endocrinology and metabolism.

[8]  R. Bouillon,et al.  Hormonal and volumetric long term control of a growth hormone-releasing hormone-producing carcinoid tumor. , 1999, The Journal of clinical endocrinology and metabolism.

[9]  S. Melmed,et al.  Long-acting lanreotide induces clinical and biochemical remission of acromegaly caused by disseminated growth hormone-releasing hormone-secreting carcinoid. , 1998, The Journal of clinical endocrinology and metabolism.

[10]  S. Melmed,et al.  Current treatment guidelines for acromegaly. , 1998, The Journal of clinical endocrinology and metabolism.

[11]  R. Bouillon,et al.  Chromogranin A: its clinical value as marker of neuroendocrine tumours , 1998, European journal of clinical investigation.

[12]  J. Svensson,et al.  Acromegaly and Cushing's syndrome due to ectopic production of GHRH and ACTH by a thymic carcinoid tumour: in vitro responses to GHRH and GHRP‐6 , 1998, Clinical endocrinology.

[13]  M. Losa,et al.  Pathophysiology and clinical aspects of the ectopic GH‐releasing hormone syndrome , 1997, Clinical endocrinology.

[14]  S. Sawano,et al.  Retrospective analysis of long‐term surgical results in acromegaly: preoperative and postoperative factors predicting outcome , 1996, Clinical endocrinology.

[15]  E. Krenning,et al.  111In-octreotide scintigraphy in oncology. , 1992, Metabolism: clinical and experimental.

[16]  T. Sano,et al.  Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. , 1988, Endocrine reviews.

[17]  S. Asa,et al.  Immunohistological localization of growth hormone-releasing hormone in human tumors. , 1985, The Journal of clinical endocrinology and metabolism.

[18]  K. Kovacs,et al.  Acromegaly due to secretion of growth hormone by an ectopic pancreatic islet-cell tumor. , 1985, The New England journal of medicine.

[19]  N. Ling,et al.  Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[20]  W. Vale,et al.  Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour , 1982, Nature.

[21]  N. Ling,et al.  Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. , 1982, Science.

[22]  B. Corrin,et al.  ACROMEGALY CAUSED BY PULMONARY CARCINOID TUMOURS , 1976, Clinical endocrinology.

[23]  F. T. Dabek Bronchial carcinoid tumour with acromegaly in two patients. , 1974, The Journal of clinical endocrinology and metabolism.

[24]  M. Buse,et al.  Eosinophilic adenoma of the pituitary and carcinoid tumor of the rectosigmoid area. , 1961, The Journal of clinical endocrinology and metabolism.

[25]  T. Khashoggi A single institution experience , 2003 .

[26]  L. Dogliotti,et al.  Circulating chromogranin A in the assessment of patients with neuroendocrine tumours. A single institution experience. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  A. Giustina,et al.  Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[28]  S. Lamberts,et al.  Somatostatin receptor subtype expression in human tumors. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.